GetTopicDetailResponse(id=425759831ae, topicName=晚期惡性腫瘤, introduction=晚期惡性腫瘤, content=null, image=null, comments=4, allHits=968, url=https://h5.medsci.cn/topic?id=59831, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=85760, tagList=[TagDto(tagId=85760, tagName=晚期惡性腫瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2066818, encodeId=3bcf206681809, content=<a href='/topic/show?id=425759831ae' target=_blank style='color:#2F92EE;'>#晚期惡性腫瘤#</a>, objectTitle=晚期惡性腫瘤的治療：抗CD47單克隆抗體TJC4在中國(guó)啟動(dòng)臨床試驗(yàn), objectType=article, longId=175549, objectId=7fc31e5549df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fc31e5549df, replyNumber=0, likeNumber=76, createdTime=2020-05-20, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fc31e5549df, moduleTitle=晚期惡性腫瘤的治療：抗CD47單克隆抗體TJC4在中國(guó)啟動(dòng)臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7fc31e5549df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066817, encodeId=d153206681efd, content=<a href='/topic/show?id=425759831ae' target=_blank style='color:#2F92EE;'>#晚期惡性腫瘤#</a>, objectTitle=CLIN CANCER RES：Avadomide治療晚期惡性腫瘤, objectType=article, longId=158549, objectId=2594158549cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2594158549cd, replyNumber=0, likeNumber=83, createdTime=2019-06-23, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2594158549cd, moduleTitle=CLIN CANCER RES：Avadomide治療晚期惡性腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2594158549cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066816, encodeId=e344206681653, content=<a href='/topic/show?id=425759831ae' target=_blank style='color:#2F92EE;'>#晚期惡性腫瘤#</a>, objectTitle=CLIN CANCER RES：抗CD70抗體ARGX-110治療晚期惡性腫瘤, objectType=article, longId=118515, objectId=4bb81185152e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb81185152e, replyNumber=0, likeNumber=72, createdTime=2018-09-26, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb81185152e, moduleTitle=CLIN CANCER RES：抗CD70抗體ARGX-110治療晚期惡性腫瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4bb81185152e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066815, encodeId=0656206681502, content=<a href='/topic/show?id=425759831ae' target=_blank style='color:#2F92EE;'>#晚期惡性腫瘤#</a>, objectTitle=CLIN CANCER RES：TAK-117治療晚期惡性腫瘤Ⅰ期臨床試驗(yàn)結(jié)果, objectType=article, longId=112044, objectId=bb781120446e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb781120446e, replyNumber=0, likeNumber=0, createdTime=2017-09-18, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb781120446e, moduleTitle=CLIN CANCER RES：TAK-117治療晚期惡性腫瘤Ⅰ期臨床試驗(yàn)結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bb781120446e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
